Trial Profile
Prospective Randomized Controlled Study of Intravitreal Injection of 0.16 mg Bevacizumab One Day Before Surgery for Proliferative Diabetic Retinopathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 May 2013 New trial record